CEC Oncology
@CEC_Onc
Live & enduring accredited hem/onc activities for physicians (ACCME), nurses (ANCC), and pharmacists (ACPE): http://ceconcepts.com/search/special…
You might like
November is Lung Cancer Awareness Month—a time to amplify conversations about prevention, early detection, and the latest treatment advancements. 🫁 Let’s work together to spread awareness and support innovations in lung cancer care. Every effort counts in saving lives and…
In HER2-negative MBC, treatment sequencing matters. This 30-minute CE breaks down trial evidence into clinical action. 🧠 Evidence-based 🧬 Patient-first ▶️ ce.ceconcepts.com/BC-134 #ADCtherapy #CMEOncology
Early recognition. Evidence-based care. Multidisciplinary strategies. Tune in 11/21 @ 10:15 PM EST for expert discussion on NF1 & MEK inhibitors. 🔗 ce.ceconcepts.com/MMS-161 #Neurofibromatosis #NF1PN #CME
From toxicity prevention to real-world collaboration—this new CE activity covers the ADC AE essentials you need. ✔️ Interprofessional strategies ✔️ QoL focus ✔️ Only 30 minutes Start here: ce.ceconcepts.com/BC-135 #BreastCancer #MBC #ADCEducation
What makes ADCs so different from chemo? 📽️ This CE covers targeting, payloads, and patient impact in just 30 mins. 💊 For oncologists, NPs, PAs & pharmacists. ▶️ ce.ceconcepts.com/BC-133 #OncologyTwitter #MBCupdate
CAR T-cell & bispecific therapies = revolutionary 🌟 But AEs like CRS & ICANS = critical ❗ Learn how to diagnose and manage in real-time. 🧠 ce.ceconcepts.com/WCV-095 #Oncology #EmergencyMedicine #CRS #EDTraining
WATCH NOW: All Hands on Deck – Utilizing JAK Inhibitors in Myelofibrosis Care: Evidence, Timing, and Strategic Approaches. Download the resources and collect credit - ceconcepts.com/grv-059-encore/ x.com/i/broadcasts/1…
Fast, focused, free. Learn to select ADCs for HER2-negative MBC using new trial data & expert insight—in just 30 minutes. 🎥 ce.ceconcepts.com/BC-134 #BreastCancerCME #ADCTreatment #MBCeducation
🎯 Calling neuro-oncologists, oncologists, NPs & nurses: This one’s for you! Learn how to integrate MEK inhibitors into NF1 care on 11/21. 🔗 ce.ceconcepts.com/MMS-161 #NF1Care #TeamBasedCare #MedEd
WATCH NOW: All Hands on Deck: A Focus on Current and Emerging Treatment Options in the Frontline Setting for Peripheral T-cell Lymphoma. Download the resources and collect credit - ceconcepts.com/grv-064-encore/ x.com/i/broadcasts/1…
📣 Nurses, PAs, oncologists, and pharmacists: Want actionable tips on managing ADC toxicities? This new BriefCase offers exactly that—plus a powerful patient story to guide care. 🔗 ce.ceconcepts.com/BC-135 #HER2Negative #ADC #CancerSupport #OncologyCME
Thank you to everyone who joined the live webcast! The activity is now available on demand—watch the archive or share it with colleagues today. 🎯 Put what you’ve learned into action: ✔️ Improve familiarity with desmoid tumor symptoms to better identify patients ✔️ Strengthen…
Get a fast but deep dive into antibody-drug conjugates and their evolving role in HER2-negative MBC. ⏱️ Only 30 minutes. 📍 ce.ceconcepts.com/BC-133 #ADCTherapy #BreastCancerEd #NPs
💬 “What’s the best sequencing strategy for ADCs in HER2-negative MBC?” Find out in this expert-led CE activity. ✅ 30-minute format ✅ Patient perspectives included 🎓 ce.ceconcepts.com/BC-134 #ADCs #BreastCancerUpdates
We’re excited to sponsor the session at #CMEpalooza— “Grant Anatomy 101: Dissecting A Grant Proposal” at 10 AM ET, Wednesday, October 22 at 10am ET! View the agenda and get in on the action: cmepalooza.com/fall-2025/ Dive into key questions: How long should your needs assessment…
💡 MEK inhibitors are changing the game in NF1-associated PN care. Don’t miss this live CE Concepts symposium on 11/21 at 10:15 PM EST. 🔗 ce.ceconcepts.com/MMS-161 #MEKinhibitors #NF1 #OncologyCME
How do you: ✅ Anticipate toxicity? ✅ Keep patients on treatment? ✅ Elevate their quality of life? It starts with this 30-minute BriefCase on ADC-associated AEs in HER2-negative MBC → ce.ceconcepts.com/BC-135 #OncNurses #Pharmacists #NPs #CE
💡 The MEKtrix: Decoding the Real-World Impact of Therapeutic Advances in Neurofibromatosis Type 1–Associated Plexiform Neurofibroma Management Across Pediatric and Adult Populations Thank you for joining the live webcast! The activity is now available on demand—watch the…
ceconcepts.com
The MEKtrix: Decoding the Real-World Impact of Therapeutic Advances in Neurofibromatosis Type...
Neurofibromatosis type 1 (NF1) presents unique diagnostic and management challenges due to its multisystem involvement and complex neuro-oncologic manifestations. Despite recent advances, including...
United States Trends
- 1. GTA 6 7,471 posts
- 2. GTA VI 13K posts
- 3. Rockstar 40.1K posts
- 4. #LOUDERTHANEVER 1,483 posts
- 5. Nancy Pelosi 110K posts
- 6. GTA 5 6,233 posts
- 7. Paul DePodesta 1,542 posts
- 8. Rockies 3,434 posts
- 9. Grand Theft Auto VI 31.9K posts
- 10. Ozempic 14.5K posts
- 11. Antonio Brown 2,602 posts
- 12. $TSLA 52.5K posts
- 13. GTA 7 N/A
- 14. Elon Musk 215K posts
- 15. Luke Fickell N/A
- 16. RFK Jr 25.9K posts
- 17. Marshawn Kneeland 58.8K posts
- 18. Michael Jackson 87K posts
- 19. Jonah Hill 1,401 posts
- 20. Justin Dean N/A
You might like
-
EGFR Resisters Research Summit
@EGFRSummit -
Melissa L. Johnson
@MLJohnsonMD2 -
Misako Nagasaka
@MNagasaka -
Johns Hopkins Thoracic Oncology
@HopkinsThoracic -
Brian Henick
@BHenickMD -
OncoViews
@OncoViews -
Patrick C. Ma, MD
@PatrickCMa1 -
Joni Fowler, PharmD
@jfowlerpharmd -
CE Concepts
@CE_Concepts -
Vun-Sin Lim, PhD
@vs_lim
Something went wrong.
Something went wrong.